Background: School-based caries prevention using silver diamine fluoride (SDF) has been shown to effectively prevent and control dental caries. To better inform program design and implementation, this paper estimated transition probabilities for dental caries in a school SDF program. Methods: The CariedAway project was a pragmatic, cluster-randomized trial of school-based caries prevention interventions conducted in predominately low-income minority children. For children in CariedAway receiving SDF, transition probabilities were computed between sound, carious, and arrested states for 6-year molars using multistate Markov models. Subject-level transition probabilities over one- and two-year periods were then calculated by aggregating states of all 6-year molars and first and second bicuspids. Results: A total of 7418 children were enrolled in CariedAway, of which 1352 met inclusion criteria for this study. Of eligible participants, the baseline prevalence of untreated decay was 29% and the prevalence of dental sealants was 8%. The probability of transitioning between sound and carious states in 6-year molars ranged from 0.0022 to 0.0074. At the subject-level, the sound to carious transition probabilities were 0.07 and 0.12 after one and two years, respectively. Once in a fully arrested state, the probability of remaining arrested was 0.72 and 0.60 after one and two years. Conclusions: The overall probabilities of teeth remaining in diseased-free or arrested states was high after receiving silver diamine fluoride, although multiple applications might be needed for consistent caries arrest.

The authors have declared no competing interest.

NCT03442309

Research presented in this report was funded by the Patient-Centered Outcomes Research Institute (PCS-160936724).

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The CariedAway study received approval from the New York University School of Medicine Institutional Review Board (#i7-00578).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data available: Yes Data types: Data dictionary How to access data: Data dictionaries will be available to interested researchers upon request to the authors (ryan.ru=@nyu.edu) When available: beginning date: 06-01-2025 Supporting Documents Document types: Informed consent form How to access documents: Informed consent forms will be available to interested researchers upon request to the authors (ryan.ruff@nyu.edu) When available: beginning date: 06-01-2025 Additional Information Who can access the data: Interested researchers upon request to the authors (ryan.ruff@nyu.edu) Types of analyses: For any purpose Mechanisms of data availability: After approval of a proposal and a signed data access agreement.